Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection
- PMID: 28507105
- PMCID: PMC5487643
- DOI: 10.1128/AAC.00316-17
Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection
Abstract
Methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) often lead to severe complications despite the availability of effective antibiotics. It remains unclear whether elevated vancomycin MICs are associated with worse outcomes. We conducted a 2-year retrospective cohort study (n = 252) of patients with MSSA BSIs at a tertiary care hospital. We defined reduced vancomycin susceptibility (RVS) as a Microscan MIC of 2 mg/liter. All strains were genotyped (spa) and assessed for agr functionality. Multivariable logistic regression models were used to examine the impact of RVS phenotype and strain genotype on 30-day all-cause mortality and complicated bacteremia (metastatic spread, endovascular infection, or duration ≥3 days). One-third of patients (84/252) were infected with RVS isolates. RVS Infections were more frequently associated with metastatic or embolic sites of infection (36% versus 17%, P < 0.001), and endovascular infection (26% versus 12%, P = 0.004). These infections occurred more often in patients with fewer underlying comorbidities (Charlson comorbidity index of ≥3 [73% versus 88%, P = 0.002]). Genotyping identified 127 spa-types and 14 Spa-clonal complexes (Spa-CCs). Spa-CC002 and Spa-CC008 were more likely to exhibit the RVS phenotype versus other Spa-CCs (OR = 2.2, P < 0.01). The RVS phenotype was not significantly associated with 30-day mortality; however, it was associated with complicated bacteremia (adjusted odds ratio of 2.35 [range, 1.26 to 4.37]; P = 0.007) in adjusted analyses. The association of RVS strains with complicated infection and fewer underlying comorbidities suggests the phenotype as a potential marker of strain virulence in MSSA BSIs. The RVS phenotype itself was not a significant predictor of mortality in this patient cohort. Further studies are necessary to explore this host-pathogen relationship.
Keywords: MSSA bacteremia; reduced vancomycin susceptibility.
Copyright © 2017 American Society for Microbiology.
Figures
Similar articles
-
Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.Infect Control Hosp Epidemiol. 2012 Feb;33(2):160-6. doi: 10.1086/663708. Epub 2011 Dec 20. Infect Control Hosp Epidemiol. 2012. PMID: 22227985 Free PMC article.
-
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27431221 Free PMC article. Clinical Trial.
-
Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.Pediatr Infect Dis J. 2021 May 1;40(5):429-433. doi: 10.1097/INF.0000000000002992. Pediatr Infect Dis J. 2021. PMID: 33196562 Free PMC article.
-
Staphylococcus aureus bacteremia, risk factors, complications, and management.Crit Care Clin. 2013 Jul;29(3):547-62. doi: 10.1016/j.ccc.2013.03.008. Crit Care Clin. 2013. PMID: 23830653 Review.
-
Effect of the vancomycin minimum inhibitory concentration on clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.BMJ Open. 2021 Jan 15;11(1):e040675. doi: 10.1136/bmjopen-2020-040675. BMJ Open. 2021. PMID: 33452189 Free PMC article.
Cited by
-
Association of Vancomycin MIC and Molecular Characteristics with Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children.Antimicrob Agents Chemother. 2018 Apr 26;62(5):e00084-18. doi: 10.1128/AAC.00084-18. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29530845 Free PMC article.
-
The Cefazolin Inoculum Effect and the Presence of type A blaZ Gene according to agr Genotype in Methicillin-Susceptible Staphylococcus aureus Bacteremia.Infect Chemother. 2019 Dec;51(4):376-385. doi: 10.3947/ic.2019.51.4.376. Infect Chemother. 2019. PMID: 31898425 Free PMC article.
-
Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.BMC Infect Dis. 2018 Mar 5;18(1):107. doi: 10.1186/s12879-018-3011-2. BMC Infect Dis. 2018. PMID: 29506483 Free PMC article.
-
Impact of agr Functionality on the Outcome of Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia.Microbiol Spectr. 2021 Sep 3;9(1):e0011621. doi: 10.1128/Spectrum.00116-21. Epub 2021 Aug 11. Microbiol Spectr. 2021. PMID: 34378959 Free PMC article.
-
Antistaphylococcal Penicillin vs Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Spinal Epidural Abscesses.Open Forum Infect Dis. 2021 Feb 16;8(3):ofab071. doi: 10.1093/ofid/ofab071. eCollection 2021 Mar. Open Forum Infect Dis. 2021. PMID: 33738321 Free PMC article. Review.
References
-
- Khatib R, Sharma M, Iyer S, Fakih MG, Obeid KM, Venugopal A, Fishbain J, Johnson LB, Segireddy M, Jose J, Riederer K. 2013. Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates. Am J Infect Control 41:210–213. doi:10.1016/j.ajic.2012.03.038. - DOI - PubMed
-
- Turnidge JD, Kotsanas D, Munckhof W, Roberts S, Bennett CM, Nimmo GR, Coombs GW, Murray RJ, Howden B, Johnson PD, Dowling K; Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis. 2009. Staphylococcus aureus bacteremia: a major cause of mortality in Australia and New Zealand. Med J Aust 191:368–373. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources